PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Clinical trial NCT00867815 · TERMINATED
Trial details
- NCT number
- NCT00867815
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-13
- Primary completion
- 2017-12-29
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.